Fractyl Health, Inc. (GUTS)Healthcare | Biotechnology | Burlington, United States | NasdaqGM
0.58 USD
0.00
(-0.087%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 0.60 +0.02 (4.330%) ⇧ (April 21, 2026, 7:59 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 19, 2026, 12:34 a.m. EDT
While the price action suggests a fragile trend reversal, fundamental cancer with negative earnings, a P/B ratio of 9.2x, and a -5.8% predicted directional drift indicates that any rally is likely trapped selling or low-margin speculation. |
| Model | MAE |
|---|---|
| MSTL ✓ | 1.482858 |
| AutoETS | 1.486030 |
| AutoARIMA | 1.819573 |
| AutoTheta | 1.823217 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 60% |
| H-stat | 0.99 |
| Ljung-Box p | 0.827 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 29.65 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 651.787 |
| Market Cap | 91,223,152 |
| Forward P/E | -1.01 |
| Beta | 1.19 |
| Website | https://fractyl.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.55 |
| Address1 | 3 Van de Graaff Drive |
| Address2 | Suite 200 |
| All Time High | 14.5 |
| All Time Low | 0.377 |
| Ask | 0.6048 |
| Ask Size | 16 |
| Average Daily Volume10 Day | 1,425,930 |
| Average Daily Volume3 Month | 5,281,804 |
| Average Volume | 5,281,804 |
| Average Volume10Days | 1,425,930 |
| Beta | 1.189 |
| Bid | 0.5475 |
| Bid Size | 7 |
| Book Value | 0.062 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.575 |
| Current Ratio | 4.778 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.6188 |
| Day Low | 0.5637 |
| Debt To Equity | 651.787 |
| Display Name | Fractyl Health |
| Earnings Call Timestamp End | 1,774,384,200 |
| Earnings Call Timestamp Start | 1,774,384,200 |
| Earnings Timestamp | 1,774,382,400 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -95,687,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.745 |
| Enterprise Value | 71,329,152 |
| Eps Current Year | -0.652 |
| Eps Forward | -0.568 |
| Eps Trailing Twelve Months | -1.86 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.46832 |
| Fifty Day Average Change | 0.106679976 |
| Fifty Day Average Change Percent | 0.2277929 |
| Fifty Two Week Change Percent | -55.0 |
| Fifty Two Week High | 3.03 |
| Fifty Two Week High Change | -2.455 |
| Fifty Two Week High Change Percent | -0.81023103 |
| Fifty Two Week Low | 0.377 |
| Fifty Two Week Low Change | 0.19799998 |
| Fifty Two Week Low Change Percent | 0.5251989 |
| Fifty Two Week Range | 0.377 - 3.03 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,706,884,200,000 |
| Float Shares | 136,128,743 |
| Forward Eps | -0.568 |
| Forward P E | -1.0123239 |
| Free Cashflow | -56,585,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 100 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.013200001 |
| Held Percent Institutions | 0.74925005 |
| Implied Shares Outstanding | 158,648,963 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,024-02-02 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts. |
| Long Name | Fractyl Health, Inc. |
| Market | us_market |
| Market Cap | 91,223,152 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_154091089 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -140,954,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 91,223,153 |
| Number Of Analyst Opinions | 5 |
| Open | 0.58 |
| Operating Cashflow | -90,328,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 902 8800 |
| Post Market Change | 0.02490002 |
| Post Market Change Percent | 4.330438 |
| Post Market Price | 0.5999 |
| Post Market Time | 1,776,815,990 |
| Previous Close | 0.5755 |
| Price Eps Current Year | -0.8819018 |
| Price Hint | 4 |
| Price To Book | 9.274194 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.449 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.000500023 |
| Regular Market Change Percent | -0.086885 |
| Regular Market Day High | 0.6188 |
| Regular Market Day Low | 0.5637 |
| Regular Market Day Range | 0.5637 - 0.6188 |
| Regular Market Open | 0.58 |
| Regular Market Previous Close | 0.5755 |
| Regular Market Price | 0.575 |
| Regular Market Time | 1,776,801,601 |
| Regular Market Volume | 2,123,724 |
| Return On Assets | -0.52737 |
| Return On Equity | -7.44174 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 158,648,963 |
| Shares Percent Shares Out | 0.0375 |
| Shares Short | 5,957,044 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 13,162,054 |
| Short Name | Fractyl Health, Inc. |
| Short Percent Of Float | 0.0427 |
| Short Ratio | 2.25 |
| Source Interval | 15 |
| State | MA |
| Symbol | GUTS |
| Target High Price | 8.0 |
| Target Low Price | 2.0 |
| Target Mean Price | 5.24 |
| Target Median Price | 6.2 |
| Total Cash | 81,540,000 |
| Total Cash Per Share | 0.514 |
| Total Debt | 61,646,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.86 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.227425 |
| Two Hundred Day Average Change | -0.652425 |
| Two Hundred Day Average Change Percent | -0.5315396 |
| Type Disp | Equity |
| Volume | 2,123,724 |
| Website | https://fractyl.com |
| Zip | 1,803 |